向基因插入:CRISPR药物开发的尖端,血友病作为一个亮点
Zhenjie Zhang1,2, Siqi Zhang1, Hoi Ting Wong1
1School of Biomedical Sciences, Faculty of Medicine, CUHK-GIBH CAS Joint Research Laboratory on Stem Cell and Regenerative Medicine, The Chinese University of Hong Kong, Room 105A, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, Shatin, NT, Hong Kong SAR, China.
概括
基因编辑为遗传性疾病提供了新的希望. 本综述探讨了用于治疗的体内基因插入,重点关注血友病,并讨论了临床试验的挑战.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 像CRISPR/Cas9这样的基因编辑技术显示出治疗遗传疾病的前景.
- 目前的人类试验主要集中在基因破坏或删除上.
- 向基因插入提供治疗优势,但面临技术和安全障碍.
研究的目的:
- 审查临床前的进步在体内有针对性的基因插入用于治疗的应用.
- 通过系统输送突出利用基因插入用于体质固体组织的进展.
- 检查血友病作为基因插入策略的疾病模型.
主要方法:
- 对近期临床前研究的综述体内向基因插入.
- 插入策略,DNA修复途径和捐赠者设计的分析.
- 专注于系统性输送到体质固体组织.
主要成果:
- 临床前研究表明,体内基因插入具有治疗效益的潜力.
- 插入策略和捐赠者设计方面的进展正在出现.
- 血友病是评估基因插入方法的关键模型.
结论:
- 向基因插入具有显著的治疗潜力,特别是在血友病等疾病中.
- 克服技术挑战和安全问题对于临床翻译至关重要.
- 需要进一步的研究和开发,以便将基因插入疗法推进到人体试验.
相关概念视频
CRISPR
50.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.9K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K


